• An increased percentage of BTLA+CD4+ T cells in critically ill patients associated with poor outcomes and a longer hospital length of stay; thus, future studies are warranted examining BTLA expression on CD4+ T cells as a potential biomarker for subsequent infections and poor septic outcomes. The gene discussed is BTLA; the disease is infection.